Abstract: The invention relates to the preparation of lyophilized, absorbed polyvalent vaccines. According to the invention tetanus, diphtheria, pertussis and optionally typhus antigens concentrated to 5 to 15 doses/3 ml are adsorbed at a pH value of 3 to 6 to an insoluble carrier concentrated in the same way as the antigens, then the pH of the mixture is adjusted to a value of 5 to 6 and lyophilized together with a protective material commonly used in lyophilizing processes. Before administration the lyophilized vaccine is diluted to the concentration required by a physiological saline buffered to a pH value of 6.8 to 7 by a phosphate solution.
Type:
Grant
Filed:
February 22, 1984
Date of Patent:
March 25, 1986
Assignee:
Human Oltoanyagtermelo Es Kutato Intezet
Abstract: The invention relates to water-soluble alkali salts of mono- and disulfonic acid derivatives and mono- and disulfonamide derivatives of 6,6'-methylene-bis-(2,2,4-trimethyl-1,2-dihydroquinoline) and dimer and/or trimer condensation products thereof bound with a methylene bridge at the 8 or 8' position. The new compounds are radioprotective and radiosensibilizers at the same time, and may be used both in the therapy and prophylaxis of malignant tumors.
Type:
Grant
Filed:
May 14, 1982
Date of Patent:
April 9, 1985
Assignees:
Material Vegyipari Szovetkezet, Human Oltoanyagtermelo Es Kutato Intezet
Inventors:
Vilmos Bar, Jozsef Boszormenyi, Peter Richter, Jeno Mercz, Tamas Rozsnyai
Abstract: Adjuvant particles are prepared from lipoid-soluble substances, and compositions comprising the particles and biologically active substances adsorbed thereon are provided. The adjuvant systems are capable of binding a wide variety of biologically active substances, and can be used in vivo and in vitro as well.
Type:
Grant
Filed:
December 19, 1980
Date of Patent:
August 2, 1983
Assignee:
Human Oltoanyagtermelo es Kutato Intezet
Abstract: The invention relates to water-soluble alkali salts of mono- and disulfonic acid derivatives and mono- and disulfonamide derivatives of 6,6'-methylene-bis-(2,2,4-trimethyl-1,2-dihydroquinoline) and dimer and/or trimer condensation products thereof bound with a methylene bridge at the 8 or 8' position. The new compounds are radioprotective and radiosensibilizers at the same time, and may be used both in the therapy and prophylaxis of malignant tumors.
Type:
Grant
Filed:
July 2, 1980
Date of Patent:
October 26, 1982
Assignees:
Material Vegyipari Szovetkezet, Human Oltoanyagtermelo es Kutato Intezet
Inventors:
Vilmos Bar, Joszef Boszormenyi, Peter Richter, Jeno Mercz, Tamas Rozsnyai
Abstract: A biological dressing for open wounds, especially large-area burn wounds, is formed by removing free hemoglobin from a red blood cell concentrate which is subjected to hemolysis. The product thus contains the stroma, subcellular elements and precipitated protein from the human red blood corpuscle concentrate freed from the hemoglobin and can be used in a pulverulant or layer form with, if desired, an appropriate support.
Type:
Grant
Filed:
March 11, 1981
Date of Patent:
September 7, 1982
Assignee:
Human Oltoanyagtermelo es Kutato Intezet